Suet-Lin Chia

Suggest Changes
  • Citations Per Year
Learn More
Enadenotucirev (EnAd) is a group B oncolytic adenovirus developed for systemic delivery and currently undergoing clinical evaluation for advanced cancer therapy. For differentiated carcinomas,(More)
  • 1